DK214689A - Farmaceutiske midler - Google Patents

Farmaceutiske midler Download PDF

Info

Publication number
DK214689A
DK214689A DK214689A DK214689A DK214689A DK 214689 A DK214689 A DK 214689A DK 214689 A DK214689 A DK 214689A DK 214689 A DK214689 A DK 214689A DK 214689 A DK214689 A DK 214689A
Authority
DK
Denmark
Prior art keywords
therapeutically active
pharmaceutical agents
weight
tablet
examples
Prior art date
Application number
DK214689A
Other languages
Danish (da)
English (en)
Other versions
DK214689D0 (da
Inventor
Gordon France
Graham Stanley Leonard
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP88304008A external-priority patent/EP0294933B1/de
Priority claimed from GB888820265A external-priority patent/GB8820265D0/en
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of DK214689D0 publication Critical patent/DK214689D0/da
Publication of DK214689A publication Critical patent/DK214689A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK214689A 1988-05-04 1989-05-02 Farmaceutiske midler DK214689A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP88304008A EP0294933B1 (de) 1987-05-08 1988-05-04 Pharmazeutische Zusammensetzungen
GB888820265A GB8820265D0 (en) 1988-08-26 1988-08-26 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
DK214689D0 DK214689D0 (da) 1989-05-02
DK214689A true DK214689A (da) 1989-11-05

Family

ID=26116144

Family Applications (1)

Application Number Title Priority Date Filing Date
DK214689A DK214689A (da) 1988-05-04 1989-05-02 Farmaceutiske midler

Country Status (14)

Country Link
EP (1) EP0349103B1 (de)
JP (1) JP2635407B2 (de)
KR (1) KR890016963A (de)
AT (1) ATE82680T1 (de)
AU (1) AU620866B2 (de)
DE (1) DE68903605T2 (de)
DK (1) DK214689A (de)
ES (1) ES2052911T3 (de)
GR (1) GR3006498T3 (de)
IE (1) IE62728B1 (de)
MY (1) MY104010A (de)
NZ (1) NZ228970A (de)
PH (1) PH25173A (de)
PT (1) PT90466B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8730011D0 (en) * 1987-12-23 1988-02-03 Smithkline Dauelsberg Pharmaceutical compositions
CA2052679C (en) * 1990-08-30 1997-12-02 Edward J. Roche Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
US5260072A (en) * 1990-08-30 1993-11-09 Mcneil-Ppc, Inc. Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
ES2174849T3 (es) * 1992-06-04 2002-11-16 Smithkline Beecham Corp Composiciones farmaceuticas con sabor agradable.
GB9221414D0 (en) * 1992-10-13 1992-11-25 Glaxo Group Ltd Pharmaceutical compositions
HUT72408A (en) * 1993-09-10 1996-04-29 Egyt Gyogyszervegyeszeti Gyar Process for producing tablets containing acetyl-salicylic acid
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
AU733032C (en) * 1996-06-14 2002-01-03 Kyowa Hakko Kirin Co., Ltd. Intraorally rapidly disintegrable tablet
US6537525B1 (en) * 1997-01-29 2003-03-25 Douglas H. West Medicated chewing-gum
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
CA2305179A1 (en) * 1997-09-30 1999-04-08 Daiichi Pharmaceutical Co., Ltd. Oral administration preparation
US7842308B2 (en) 2001-01-30 2010-11-30 Smithkline Beecham Limited Pharmaceutical formulation
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
JP2004107258A (ja) * 2002-09-18 2004-04-08 Ss Pharmaceut Co Ltd 催眠用圧縮成型製剤
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ589750A (en) 2004-10-21 2012-07-27 Aptalis Pharmatech Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
JP2006342188A (ja) 2006-09-28 2006-12-21 Rohto Pharmaceut Co Ltd 口中溶解型又は咀嚼型鼻炎治療用固形内服医薬組成物
ES2668203T3 (es) 2009-12-02 2018-05-17 Adare Pharmaceuticals S.R.L. Microcápsulas de fexofenadina y composiciones que las contienen
JP2013032408A (ja) * 2012-11-22 2013-02-14 Rohto Pharmaceutical Co Ltd 口中溶解型又は咀嚼型鼻炎治療用固形内服医薬組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES412146A1 (es) * 1972-03-11 1976-01-01 Pfizer Procedimiento de obtencion de composiciones para reducir elhabito del tabaco.
NL7311319A (de) * 1972-09-01 1974-03-05
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
CA1229552A (en) * 1984-07-09 1987-11-24 Audley A. Legore Cimetidine compositions
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
KR960011236B1 (ko) * 1987-05-08 1996-08-21 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 제약학적 조성물 및 고체 제형

Also Published As

Publication number Publication date
PT90466A (pt) 1989-11-30
GR3006498T3 (de) 1993-06-21
MY104010A (en) 1993-10-30
AU620866B2 (en) 1992-02-27
EP0349103A1 (de) 1990-01-03
JPH01313420A (ja) 1989-12-18
IE891414L (en) 1989-11-04
PH25173A (en) 1991-03-27
DK214689D0 (da) 1989-05-02
DE68903605T2 (de) 1993-04-01
AU3394689A (en) 1989-11-09
JP2635407B2 (ja) 1997-07-30
ES2052911T3 (es) 1994-07-16
PT90466B (pt) 1994-08-31
DE68903605D1 (de) 1993-01-07
NZ228970A (en) 1991-09-25
ATE82680T1 (de) 1992-12-15
IE62728B1 (en) 1995-02-22
KR890016963A (ko) 1989-12-14
EP0349103B1 (de) 1992-11-25

Similar Documents

Publication Publication Date Title
DK214689A (da) Farmaceutiske midler
ATE125155T1 (de) Niedrigdosierte getrocknete pharmazeutische präparate.
MX171191B (es) Composiciones farmaceuticas de glipizida
FR2561524B1 (fr) Comprimes de principes actifs pharmaceutiques a delitement rapide, stables au stockage
ATE202473T1 (de) Rasch freisetzende tablettenkerne mit unlöslichen arzneistoffen und mit einem retardüberzug
DK555389A (da) Farmaceutisk praeparat
ATE125702T1 (de) Feste, schnell-lösliche arzneimittelzubereitung enthaltend s-(carboxymethyl)-l-cystein und/oder n-acetylcystein.
NO922807L (no) Farmasoeytiske dideoksypurinnukleosid-preparater til oraltbruk
BE893193A (fr) Composition pharmaceutique contenant du 24-25-dihydroxy-cholecalciferol a titre d'ingredient actif
DE59410151D1 (de) Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
DE69322251D1 (de) Medizinische zusammensetzung
NO995127D0 (no) Stabiliserte tibolonblandinger
SE8804628D0 (sv) New compounds
ATE97572T1 (de) Azelastin enthaltende arzneimittel mit kontrollierter wirkstoffabgabe.
ATE38151T1 (de) Bestaendige 5-adenosyl-l-methionin-salze enthaltende, pharmazeutische zusammensetzungen fuer orale anwendung.
ATE143805T1 (de) Arzneizubereitung mit hohem gehalt an ibuprofenlysinat
BG94934A (bg) Твърди лекарствени форми за орално приложение,съдържащи ифосфамид като активно вещество
DK0450123T3 (da) Farmaceutisk præparat til topisk administration indeholdende dichlofenac-natrium
DE69012031D1 (de) Optisch aktive Benzylalkoholverbindung und pharmazeutische Zusammensetzung.
GB2258397A (en) Pharmaceutical compositions containing amethocaine
DK0560207T3 (da) Præparat til oral anvendelse baseret på ibuprofen
TH14574A (th) สารผสมทางเภสัชกรรม

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment